Prevention Pharmaceuticals Report issue

For profit
Founded: New Haven CT United States (2009)
Status: No NME R&D (2009)

Organization Overview

First Clinical Trial
2015
NCT02670356
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (2)

fish oil (Omegavan) (1 trial)

krill oil (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2